Here, we present in vitro, in vivo, and clinical data defining the major repressor of c-Src, PAG1 (Phosphoprotein Associated with Glycosphingolipid-enriched microdomains 1), as a novel tumor suppressor in high-risk NB. Here, SRC is linked to neuroblastoma.